The Inhalation Ad Hoc Advisory Panel for the USP performance tests of inhalation dosage forms

Pharmacopeial Forum

Volumn 34, Issue 4, 2008, Pages 1068-1074

  Gray, Vivian A ^a   Hickey, Anthony J ^a   Balmer, Patrick ^a   Davies, Neal M ^a   Dunbar, Craig ^a   Foster, Thomas S ^a   Olsson, Bo L ^a   Sakagami, Masahiro ^a   Shah, Vinod P ^a   Smurthwaite, Michael J ^a   Veranth, John M ^a   Zaidi, Kahkashan ^a  

^a UNITED STATES PHARMACOPEIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CHLORAMPHENICOL; DIGITALIS; FLIXOTIDE ACCUHALER; FLUTICASONE PROPIONATE; GENERIC DRUG; INSULIN; IPRATROPIUM BROMIDE; PEPTIDE DERIVATIVE; PHENYLBUTAZONE; POLYLACTIC ACID; PREDNISONE; PROTEIN DERIVATIVE; RESPIRATORY TRACT AGENT; STEROID; TETRACYCLINE DERIVATIVE; TRIAMCINOLONE ACETONIDE;

ALLERGIC RHINITIS; ARTICLE; ASTHMA; BRONCHODILATATION; DRUG ABSORPTION; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; DRUG PURITY; DRUG QUALITY; DRUG RELEASE; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; FLOW RATE; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; IN VITRO STUDY; IN VIVO STUDY; INHALATIONAL DRUG ADMINISTRATION; LUNG ALVEOLUS CELL; MEDICAL LITERATURE; METERED DOSE INHALER; NEBULIZER; NONHUMAN; PARTICLE SIZE; QUALITY CONTROL; STANDARDIZATION;

EID: 48349127479     PISSN: 03634655     EISSN: 15421945     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Marshall K, Foster TS, Carlin HS, Williams RL. Development of a compendial taxonomy and glossary for pharmaceutical dosage forms. Pharm Forum. 2003;29(5):1742-1752.
2. US Pharmacopeial Convention, Inc. USP 30-NF 25. Rockville, MD: USP; 2007.
3. Lindenbaum J, Butler VP Jr, Murphy JE, Cresswell RM. Correlation of digoxin-tablet dissolution-rate with biological availability. Lancet. 1973;(7814):1215-1217.
4. Kakemi K, Arita T, Ohashi S. The absorption and excretion of drugs. XV. Dissolution of chloramphenicol sustained-release granules and its blood level. Jpn J Pharmacol. 1962;82:1476-1479.
5. Nelson E. Influence of dissolution rate and surface on tetracycline absorption. J Am Pharm Assoc Am Pharm Assoc (Baltimore). 1959;48(2):96-103.
6. Hom FS, Miskel JJ. Oral dosage form design and its influence on dissolution rates for a series of drugs. J Pharm Sci. 1970;59(6):827-830.
7. Parrott EL, Wurster DE, Highuchi T. Investigation of drug release from solids. I. some factors influencing the dissolution rate. J Am Pharm Assoc Am Pharm Assoc (Baltimore). 1955;44(5):269-273.
8. Fraser EJ, Leach RH, Poston JW, Bold AM, Culank LS, Lipede AB. Dissolution and bioavailability of digoxin tablets. J Pharm Pharmacol. 1973;25:968-973.
9. Bell H, Johansen H, Lunde PKM, et al. Absorption and dissolution characteristics of 14 different oral chloramphenicol preparations tested on healthy human male subjects. Pharmacol. 1971;5:108-120.
10. Sullivan TJ, Sakmar E, Albert KS, Blair DC, Wagner JG. In vitro and in vivo availability of commercial prednisone tablets. J Pharm Sci. 1975;64:1723-1725.
11. FDA. Center for Drug Evaluation and Research. Guidance for Industry: Dissolution Testing of Immediate-release Solid Oral Dosage Forms. 1997. www.fda.gov/cder/guidance/1713bp1.pdf. Accessed 26 June 2007.
12. Hardy JG, Chadwick TS. Sustained release drug delivery to the lungs. An option for the future. Clin Pharmacokin. 2000;39:1-4.
13. Moss OR. Simulants of lung interstitial fluid. Health Phys. 1979;36:447-448.
14. Widdicombe JG. Airway liquid: a barrier to drug diffusion? Eur Respir J. 1997;10:2194-2197.
15. Taylor MK, Hickey AJ, Van Oort M. Manufacture, characterization, and pharmacodynamic evaluation of engineered ipratropium bromide particle. Pharm Dev Technol. 2006;11(3):321-336.
16. Davies NM, Feddah MR. A novel method for assessing dissolution of aerosol inhaler products. Int J Pharm. 2003;255:175-187.
17. Arya V, Coowanitwong I, Burgos B, Kim WS, Singh R, Hochaus G. Pulmonary targeting of sustained release formulation of budesonide in neonatal rats. J Drug Target. 2006;14:680-686.